335 related articles for article (PubMed ID: 28382716)
21. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
Zhang X; Yang K; Chen S; Ji Y
J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
[TBL] [Abstract][Full Text] [Related]
22. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
25. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
MacFarland SP; Sullivan LM; States LJ; Bailey LC; Balamuth NJ; Womer RB; Olson TS
J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
[TBL] [Abstract][Full Text] [Related]
26. Intestinal obstruction due to kaposiform hemangioendothelioma in a 1-month-old infant: A case report.
Youn JK; Park SH; Han JW; Oh C; Kim HY; Jung SE
Medicine (Baltimore); 2017 Sep; 96(37):e6974. PubMed ID: 28906349
[TBL] [Abstract][Full Text] [Related]
27. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon.
Zhang G; Gao Y; Liu X
Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059
[No Abstract] [Full Text] [Related]
28. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
Ji Y; Chen S; Yang K; Xia C; Peng S
J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
[TBL] [Abstract][Full Text] [Related]
29. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
[TBL] [Abstract][Full Text] [Related]
30. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
del Pozo J; López-Gutiérrez JC; Gómez-Tellado M; Nistal M; Soler R; Sacristán F; Tovar JA
Pediatr Dermatol; 2011; 28(4):439-43. PubMed ID: 20403115
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
32. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
33. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
[TBL] [Abstract][Full Text] [Related]
34. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
36. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
Croteau SE; Gupta D
Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
[TBL] [Abstract][Full Text] [Related]
37. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
Wang C; Li Y; Xiang B; Li F; Chen S; Li L; Ji Y
Pancreas; 2017; 46(5):e39-e41. PubMed ID: 28426496
[No Abstract] [Full Text] [Related]
38. A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus.
Dang N; Ren Y
Vasc Health Risk Manag; 2024; 20():251-254. PubMed ID: 38883398
[TBL] [Abstract][Full Text] [Related]
39. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic features of kaposiform hemangioendothelioma].
Tang HF; Zhou YY; Gu WZ; Li MJ
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1132-5. PubMed ID: 15498303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]